Références

1. Headache Classification Committee of the International Headache Society (IHS), The International Classification of Headache Disorders, 3rd edition (beta version), Cephalagia, 33(9), 2013, p. 629-808.

2. L. Stovner, K. Hagen, R. Jensen et al., « The global burden of headache: a documentation of headache prevalence and disability worldwide », Cephalagia, 27, 2007, p. 193-210.

3. A.H. Schramm, M. Obermann, Z. Katsarava et al., « Epidemiological profiles of patients with chronic migraine and chronic tension-type headache », The Journal of Headache and Pain, 14, 2013, p. 40.

4. T. Vos, A.D. Flaxman, M. Naghavi et al., « Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 », The Lancet, 380(9859), 2012, p. 2163-2196.

5. A.N. Manack, D.C. Buse et R.B. Lipton, « Chronic migraine: Epidemiology and disease burden », Current Pain and Headache Reports, 15, 2011, p. 70-78.

6. K.R. Merikangas, « Contributions of epidemiology to our understanding of migraine », Headache, 53(2), 2013, p. 230-246.

7. Dorland’s Illustrated Medical Dictionary, Philadelphia, Pennsylvania, W.B. Saunders Co., 1994.

8. B. O’Brien, R. Goeree et D. Streiner, « Prevalence of migraine headache in Canada: A population-based survey », International Journal of Epidemiology, 23(5), 1994, p. 1020-1026.

9. L.J. Cooke  et W.J. Becker, « Migraine prevalence, treatment and impact: the Canadian women and migraine study », Canadian Journal of Neurological Sciences, 37, 2010, p. 580-587.

10. L.J. Stovner et C. Andrée, «  Prevalence of headache in Europe: a review for the Eurolight project », Journal of Headache and Pain, 11, 2010, p. 289-299.

11. T.A. Smitherman, R. Burch, H. Sheikh et E. Loder, « The prevalence, impact and treatment of migraine and severe headaches in the United States: A review of statistics from National Surveillance Studies », Headache, 53(3), 2013, p. 427-436.

12. M. Ertas, B. Baykan, E.K. Orhan et al., « One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults », Journal of Headache Pain, 13, 2012, p. 147-157.

13. J. Matias-Guiu, C. Fernandez, J. Porta-Etessam et al., « Factors associated with the differences in migraine prevalence rates between Spanish regions », The Scientific World Journal, article ID 323084, 2014, 6 pages.

14. V. Pfaffenrath,  K. Fendrich, M. Vennemann et al., « Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study », Cephalagia, 29(1), 2009, p. 48-57.

15. L.J. Stovner, M. Al Jumah, G.L. Birbeck et al., « The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache », The Journal of Headache and Pain, 15, 2014, p. 5.

16. R.B. Lipton, D. Dodick, R. Sadovsky et al., « A self-administered screener for migraine in primary care: The ID MigraineTM validation study », Neurology, 61(3), 2003, p. 375-382.

17. A.M. Rapoport et M.E. Bigal, « ID-migraine », Neurological Sciences, 24, 2004, p. S258-260.

18.K. Kroenke, R.L. Spitzer et J.B. Williams, « The PHQ-9: Validity of a brief depression severity measure », Journal of General Internal Medicine, 16(9), 2001, p. 606-613.

19. J.N.K. Rao, C.F.J. Wu et K. Yue, « Quelques travaux récents sur les méthodes de rééchantillonnage applicables aux enquêtes complexes », Techniques d’enquête, 18(2), 1992, p. 225-234 (Statistique Canada, n^o 12-001 au catalogue).

20. K.F. Rust et J.N.K. Rao, « Variance estimation for complex surveys using replication techniques », Statistical Methods in Medical Research, 5,1996, p. 281-310.

21. D. Serrano, A.N. Manack, M.L. Reed et al., « Cost and predictors of lost productive time in chronic migraine and episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study », Value in Health, 16, 2013, p. 31-38.

22. N. Breslau, R.B. Lipton, W.F. Stewart et al., « Comorbidity of migraine and depression: investigating potential etiology and prognosis », Neurology, 60, 2003, p. 1308-1312.

23. N. Jette, S. Patten, J. Williams et al., « Comorbidity of migraine and psychiatric disorders: a national population-based study », Headache, 48(4), 2008, p. 501-516.

24. M.E. Bigal et R.B. Lipton, « The epidemiology, burden, and comorbidities of migraine », Neurologic Clinics, 27(2), 2009, p. 321-334.

25. G. Bruti, M.C. Magnotti et G. Iannetti, « Migraine and depression : bidirectional co-morbidities? », Neurological Sciences, 33(Suppl .1), 2012, p. S107-109.

26. M. Stokes, W.J. Becker, R.B. Lipton et al., « Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS) », Headache, 51, 2011, p. 1058-1077.

27. J.C. Sanderson, E.B. Devine, R.B. Lipton et al., « Headache-related health resource utilisation in chronic and episodic migraine across six countries », Journal of Neurology, Neurosurgery and Psychiatry, 84, 2013, p. 1309-1317.

28. W.F. Stewart, G.C. Wood, H. Razzaghi et al., « Work impact of migraine headaches », Journal of Occupational and Environmental Medicine, 50, 2008, p. 736-745.